C. Remondo

发表

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

James L. Gulley, Ira Pastan, I. Pastan, 2009, Cancer Immunology, Immunotherapy.

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients.

G. Francini, L. Paolelli, A. Pascucci, 2006, Oncology reports.

Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine

P. Tagliaferri, M. Caraglia, G. Francini, 2009, Cancer biology & therapy.

Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)

P. Tassone, P. Tagliaferri, A. Fioravanti, 2008, Clinical Cancer Research.

Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy

P. Tassone, P. Tagliaferri, G. Francini, 2010, Journal of immunotherapy.

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

S. Steinberg, J. Schlom, W. Dahut, 2008, Clinical Cancer Research.

Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients

S. F. Carbone, P. Tassone, A. Abbruzzese, 2010, Cancer biology & therapy.

Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen.

J. Schlom, H. Sabzevari, K. Tsang, 2009, Vaccine.

Immunotherapy for prostate cancer

J. Gulley, C. Remondo, 2011 .

Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis

N. Lumen, F. Ameye, B. Sautois, 2021, Acta clinica Belgica.

Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC).

M. Marra, P. Tassone, A. Abbruzzese, 2010, European journal of cancer.

Enhanced Functionality of CD 4 + CD 25 highFoxP 3 + RegulatoryTCells in the Peripheral Blood of Patients with Prostate Cancer

J. Schlom, J. Gulley, K. Tsang, 2008 .

Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer

J. Schlom, J. Gulley, K. Tsang, 2008, Clinical Cancer Research.

Identification of cytotoxic T‐lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4)

I. Pastan, J. Schlom, J. Gulley, 2007, International journal of cancer.

Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate

G. Francini, E. Francini, A. Pascucci, 2010, Journal of chemotherapy.

Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine.

M. Amacker, G. Francini, P. Correale, 2008, Cancer letters.

Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer

J. Schlom, J. Gulley, K. Tsang, 2008, Clinical Cancer Research.